Clinical deterioration without a clear precipitating change in medication or diet |
To determine candidacy for device therapy |
LVEF 3 months after MI on optimal medical therapy |
LVEF after revascularization |
For scar tissue in CRT lead placement area |
With implanted CRT and ICD devices |
For CRT programming optimization |
No improvement in symptoms/functional capacity |
Changes in arrhythmia status and ICD discharges |
To detect device complication |
Ischaemia/viability for revascularization decision |
Monitoring of cardiomyopathies during pregnancy |
Monitoring of reversible cardiomyopathies |
Peripartum cardiomyopathy |
Takotsubo cardiomyopathy |
Tachycardia-induced cardiomyopathy |
Monitoring of cancer treatment-related cardiac dysfunction |
Response to therapy in infiltrative myocardial diseases |
Routine (2 years) surveillance of known HF or cardiomyopathies in stable settings |
Left ventricular assist device decisions |
To determine candidacy |
For optimization of device settings |
To detect device-related complications |
For weaning decision |
Monitoring of rejection in cardiac transplantation |